204981-48-6

204981-48-6 structure
204981-48-6 structure
  • Name: CP-195543
  • Chemical Name: (3S,4R)-7-(2-carboxy-5-trifluoromethylphenyl)-4-hydroxy-3-benzyl-3,4-dihydro-2H-1-benzopyran
  • CAS Number: 204981-48-6
  • Molecular Formula: C24H19F3O4
  • Molecular Weight: 428.40000
  • Catalog: Signaling Pathways GPCR/G Protein Leukotriene Receptor
  • Create Date: 2016-09-12 16:53:05
  • Modify Date: 2025-08-25 17:45:34
  • CP-195543 is a potent, selective and orally active leukotriene B4 (LTB4) receptor antagonist with IC50s of 6.8, 37.0 nM for human neutrophils and murine spleen membranes, respectively. CP-195543 blocks CD11b up-regulation. CP-195543 inhibits LTB4-mediated neutrophil infiltration[1].

Name (3S,4R)-7-(2-carboxy-5-trifluoromethylphenyl)-4-hydroxy-3-benzyl-3,4-dihydro-2H-1-benzopyran
Synonyms 2-[(3S,4R)-3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)benzoic acid
(3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)-benzoic acid
Description CP-195543 is a potent, selective and orally active leukotriene B4 (LTB4) receptor antagonist with IC50s of 6.8, 37.0 nM for human neutrophils and murine spleen membranes, respectively. CP-195543 blocks CD11b up-regulation. CP-195543 inhibits LTB4-mediated neutrophil infiltration[1].
Related Catalog
Target

LTB4

In Vitro CP-195543 抑制由 LTB4 介导的人和小鼠中性粒细胞趋化性,IC50 值分别为 2.4 nM、7.5 nM[1]。 CP-195543 (0.1 nM-10 µM;60 分钟) 阻断人中性粒细胞 (HN) 和小鼠中性粒细胞中 CD11b 的上调,对人单核细胞和嗜酸性粒细胞的 IC50 值分别为 270、420 nM [1]。
In Vivo CP-195543 (0.01, 0.1, 1, 10 mg/kg for guinea pig; 0.01, 0.1, 1, 10, 100 mg/kg for mice; P.o.; 1 h before injection of LTB4) 呈剂量依赖性抑制 LTB4 介导的中性粒细胞浸润[1]。 Animal Model: Guinea pig (Injection of LTB4 10, 30, 100 ng/site; injected intradermally)[1] Dosage: 0.01, 0.1, 1, 10 mg/kg Administration: P.o.; 1 h before injection of LTB4 Result: Inhibited LTB4-mediated neutrophil infiltration in guinea pigskin in a dose-dependent manner. Animal Model: Mice (Injection of LTB4 100 ng/site; injected intradermally)[1] Dosage: 0.01, 0.1, 1, 10, 100 mg/kg Administration: P.o.; 1 h before injection of LTB4 Result: Inhibited LTB4-mediated neutrophil infiltration in guinea pigskin in a dose-dependent manner.
References

[1]. Showell HJ, et al. The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543. J Pharmacol Exp Ther. 1998 Jun;285(3):946-54.  

Molecular Formula C24H19F3O4
Molecular Weight 428.40000
Exact Mass 428.12400
PSA 66.76000
LogP 5.35530
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.